Dr. Martens plc DOCMF OTC

Other OTC • Consumer Cyclical • Apparel - Footwear & Accessories • GB • USD

SharesGrow Score

42/100

1/7 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Dr. Martens plc (DOCMF) generated $-16.09M in operating cash flow for quarter ending 2025-09-30. After capital expenditures of $4M, free cash flow was $-20M.

Free cash flow margin was -6.2% of revenue. Cash conversion ratio was 1.61x, indicating earnings are backed by cash.

The company returned $8M in dividends to shareholders during the quarter.

Criteria supported by this page:

HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (64/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
INCOME (30/100) — Cash conversion ratio was 1.61x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 42/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

42/100

SG Score

View full scorecard →

✗

VALUE

15/100

Price-to-Earnings & upside

→ Valuation

✗

FUTURE

20/100

Analyst consensus

→ Forecast

✓

PAST

100/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

64/100

Proven by this page

✗

GROWTH

15/100

→ Income

✗

INCOME

30/100

→ Income

Dr. Martens plc Cash Flow History

Metric	TTM	Q2 FY2026	Q4 FY2025	Q2 FY2025	Q4 FY2023
Operating Cash Flow	$394.65M	$-16.09M	$184.04M	$35.3M	$191.4M
Capital Expenditure	$-20.02M	$-4M	$-5.42M	$-4.2M	$-6.4M
Free Cash Flow	$374.71M	$-20M	$178.61M	$31.1M	$185M